CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer

Background: Although early-stage lung cancer has increased owing to the introduction of screening programs, high recurrence rate remains a critical concern. We aimed to explore biomarkers related to the prognosis of surgically resected non-small-cell lung cancer (NSCLC). Methods: In this retrospecti...

Full description

Bibliographic Details
Main Authors: Yunha Nam, Chang-Min Choi, Young Soo Park, HyunA Jung, Hee Sang Hwang, Jae Cheol Lee, Jung Wook Lee, Jung Eun Lee, Jung Hee Kang, Byung Hun Jung, Wonjun Ji
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Clinical Medicine
Subjects:
lung cancer
non-small-cell lung cancer
surgical resection
CDCP1
biomarker
prognosis
Online Access:https://www.mdpi.com/2077-0383/11/2/341

Internet

https://www.mdpi.com/2077-0383/11/2/341

Similar Items